nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisuride—CYP3A4—Pimecrolimus—atopic dermatitis	0.0742	0.182	CbGbCtD
Lisuride—CYP2D6—Loratadine—atopic dermatitis	0.0508	0.125	CbGbCtD
Lisuride—CYP2D6—Diphenhydramine—atopic dermatitis	0.0508	0.125	CbGbCtD
Lisuride—CYP3A4—Tacrolimus—atopic dermatitis	0.0441	0.108	CbGbCtD
Lisuride—DRD5—eyelid—atopic dermatitis	0.0351	0.584	CbGeAlD
Lisuride—CYP3A4—Loratadine—atopic dermatitis	0.0323	0.0794	CbGbCtD
Lisuride—CYP3A4—Methylprednisolone—atopic dermatitis	0.0295	0.0726	CbGbCtD
Lisuride—CYP3A4—Triamcinolone—atopic dermatitis	0.0224	0.055	CbGbCtD
Lisuride—CYP3A4—Betamethasone—atopic dermatitis	0.0192	0.0472	CbGbCtD
Lisuride—CYP3A4—Prednisolone—atopic dermatitis	0.019	0.0466	CbGbCtD
Lisuride—CYP3A4—Hydrocortisone—atopic dermatitis	0.018	0.0442	CbGbCtD
Lisuride—CYP3A4—Prednisone—atopic dermatitis	0.0179	0.044	CbGbCtD
Lisuride—CYP2D6—Dexamethasone—atopic dermatitis	0.0176	0.0432	CbGbCtD
Lisuride—CYP3A4—Dexamethasone—atopic dermatitis	0.0112	0.0275	CbGbCtD
Lisuride—DRD3—head—atopic dermatitis	0.00237	0.0394	CbGeAlD
Lisuride—DRD5—head—atopic dermatitis	0.00222	0.0369	CbGeAlD
Lisuride—HTR2B—skin of body—atopic dermatitis	0.0019	0.0315	CbGeAlD
Lisuride—ADRA1B—head—atopic dermatitis	0.00182	0.0303	CbGeAlD
Lisuride—ADRA1D—head—atopic dermatitis	0.00178	0.0296	CbGeAlD
Lisuride—Immune system disorder—Loratadine—atopic dermatitis	0.00172	0.0056	CcSEcCtD
Lisuride—Orthostatic hypotension—Tacrolimus—atopic dermatitis	0.00172	0.00559	CcSEcCtD
Lisuride—Tachycardia—Dimenhydrinate—atopic dermatitis	0.00172	0.00558	CcSEcCtD
Lisuride—Tachycardia—Diphenhydramine—atopic dermatitis	0.00172	0.00558	CcSEcCtD
Lisuride—Hyperhidrosis—Diphenhydramine—atopic dermatitis	0.0017	0.00553	CcSEcCtD
Lisuride—Hyperhidrosis—Dimenhydrinate—atopic dermatitis	0.0017	0.00553	CcSEcCtD
Lisuride—DRD1—head—atopic dermatitis	0.0017	0.0282	CbGeAlD
Lisuride—Infection—Pimecrolimus—atopic dermatitis	0.00169	0.00549	CcSEcCtD
Lisuride—Anorexia—Diphenhydramine—atopic dermatitis	0.00168	0.00545	CcSEcCtD
Lisuride—Anorexia—Dimenhydrinate—atopic dermatitis	0.00168	0.00545	CcSEcCtD
Lisuride—Nervous system disorder—Pimecrolimus—atopic dermatitis	0.00167	0.00542	CcSEcCtD
Lisuride—Insomnia—Dimenhydrinate—atopic dermatitis	0.00159	0.00517	CcSEcCtD
Lisuride—Insomnia—Diphenhydramine—atopic dermatitis	0.00159	0.00517	CcSEcCtD
Lisuride—HTR2A—neck—atopic dermatitis	0.00157	0.026	CbGeAlD
Lisuride—Somnolence—Dimenhydrinate—atopic dermatitis	0.00156	0.00508	CcSEcCtD
Lisuride—Somnolence—Diphenhydramine—atopic dermatitis	0.00156	0.00508	CcSEcCtD
Lisuride—Mediastinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00154	0.00502	CcSEcCtD
Lisuride—Decreased appetite—Diphenhydramine—atopic dermatitis	0.00153	0.00497	CcSEcCtD
Lisuride—Decreased appetite—Dimenhydrinate—atopic dermatitis	0.00153	0.00497	CcSEcCtD
Lisuride—Fatigue—Diphenhydramine—atopic dermatitis	0.00152	0.00493	CcSEcCtD
Lisuride—Fatigue—Dimenhydrinate—atopic dermatitis	0.00152	0.00493	CcSEcCtD
Lisuride—Dyspnoea—Pimecrolimus—atopic dermatitis	0.00152	0.00493	CcSEcCtD
Lisuride—Headache—Desonide—atopic dermatitis	0.00151	0.0049	CcSEcCtD
Lisuride—Constipation—Diphenhydramine—atopic dermatitis	0.0015	0.00489	CcSEcCtD
Lisuride—Constipation—Dimenhydrinate—atopic dermatitis	0.0015	0.00489	CcSEcCtD
Lisuride—Mental disorder—Fluocinolone Acetonide—atopic dermatitis	0.0015	0.00488	CcSEcCtD
Lisuride—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.00149	0.00485	CcSEcCtD
Lisuride—Syncope—Loratadine—atopic dermatitis	0.00149	0.00484	CcSEcCtD
Lisuride—Weight increased—Tacrolimus—atopic dermatitis	0.00148	0.00481	CcSEcCtD
Lisuride—Immune system disorder—Mometasone—atopic dermatitis	0.00148	0.0048	CcSEcCtD
Lisuride—Mediastinal disorder—Mometasone—atopic dermatitis	0.00148	0.00479	CcSEcCtD
Lisuride—Weight decreased—Tacrolimus—atopic dermatitis	0.00147	0.00478	CcSEcCtD
Lisuride—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00147	0.00477	CcSEcCtD
Lisuride—Palpitations—Loratadine—atopic dermatitis	0.00147	0.00477	CcSEcCtD
Lisuride—Constipation—Pimecrolimus—atopic dermatitis	0.00145	0.00473	CcSEcCtD
Lisuride—Feeling abnormal—Dimenhydrinate—atopic dermatitis	0.00145	0.00471	CcSEcCtD
Lisuride—Feeling abnormal—Diphenhydramine—atopic dermatitis	0.00145	0.00471	CcSEcCtD
Lisuride—Cough—Loratadine—atopic dermatitis	0.00145	0.00471	CcSEcCtD
Lisuride—Sweating—Tacrolimus—atopic dermatitis	0.00139	0.00452	CcSEcCtD
Lisuride—Dry mouth—Loratadine—atopic dermatitis	0.00138	0.00449	CcSEcCtD
Lisuride—HTR1B—head—atopic dermatitis	0.00137	0.0229	CbGeAlD
Lisuride—Vertigo—Fluocinolone Acetonide—atopic dermatitis	0.00134	0.00436	CcSEcCtD
Lisuride—HTR1D—head—atopic dermatitis	0.00133	0.0221	CbGeAlD
Lisuride—Nervous system disorder—Loratadine—atopic dermatitis	0.00133	0.00432	CcSEcCtD
Lisuride—Tachycardia—Loratadine—atopic dermatitis	0.00132	0.0043	CcSEcCtD
Lisuride—HTR2C—head—atopic dermatitis	0.00132	0.0219	CbGeAlD
Lisuride—Cough—Fluocinolone Acetonide—atopic dermatitis	0.0013	0.00423	CcSEcCtD
Lisuride—Hallucination—Tacrolimus—atopic dermatitis	0.0013	0.00421	CcSEcCtD
Lisuride—ADRB1—head—atopic dermatitis	0.00129	0.0215	CbGeAlD
Lisuride—Dizziness—Fluocinonide—atopic dermatitis	0.00129	0.00419	CcSEcCtD
Lisuride—Oedema peripheral—Tacrolimus—atopic dermatitis	0.00128	0.00417	CcSEcCtD
Lisuride—Asthenia—Dimenhydrinate—atopic dermatitis	0.00126	0.0041	CcSEcCtD
Lisuride—Asthenia—Diphenhydramine—atopic dermatitis	0.00126	0.0041	CcSEcCtD
Lisuride—Cough—Mometasone—atopic dermatitis	0.00124	0.00404	CcSEcCtD
Lisuride—HTR2B—head—atopic dermatitis	0.00124	0.0206	CbGeAlD
Lisuride—Insomnia—Loratadine—atopic dermatitis	0.00123	0.00398	CcSEcCtD
Lisuride—Headache—Fluocinonide—atopic dermatitis	0.00122	0.00397	CcSEcCtD
Lisuride—Infection—Fluocinolone Acetonide—atopic dermatitis	0.00121	0.00393	CcSEcCtD
Lisuride—Cardiac disorder—Tacrolimus—atopic dermatitis	0.00121	0.00393	CcSEcCtD
Lisuride—Somnolence—Loratadine—atopic dermatitis	0.0012	0.00391	CcSEcCtD
Lisuride—Nervous system disorder—Fluocinolone Acetonide—atopic dermatitis	0.00119	0.00388	CcSEcCtD
Lisuride—Dry mouth—Mometasone—atopic dermatitis	0.00119	0.00385	CcSEcCtD
Lisuride—Angiopathy—Tacrolimus—atopic dermatitis	0.00118	0.00384	CcSEcCtD
Lisuride—Immune system disorder—Tacrolimus—atopic dermatitis	0.00118	0.00382	CcSEcCtD
Lisuride—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.00117	0.00381	CcSEcCtD
Lisuride—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00117	0.0038	CcSEcCtD
Lisuride—Fatigue—Loratadine—atopic dermatitis	0.00117	0.0038	CcSEcCtD
Lisuride—Dizziness—Dimenhydrinate—atopic dermatitis	0.00116	0.00378	CcSEcCtD
Lisuride—Dizziness—Diphenhydramine—atopic dermatitis	0.00116	0.00378	CcSEcCtD
Lisuride—Constipation—Loratadine—atopic dermatitis	0.00116	0.00376	CcSEcCtD
Lisuride—Infection—Mometasone—atopic dermatitis	0.00116	0.00375	CcSEcCtD
Lisuride—Mental disorder—Tacrolimus—atopic dermatitis	0.00114	0.00371	CcSEcCtD
Lisuride—Malnutrition—Tacrolimus—atopic dermatitis	0.00113	0.00368	CcSEcCtD
Lisuride—Vomiting—Dimenhydrinate—atopic dermatitis	0.00112	0.00363	CcSEcCtD
Lisuride—Vomiting—Diphenhydramine—atopic dermatitis	0.00112	0.00363	CcSEcCtD
Lisuride—Feeling abnormal—Loratadine—atopic dermatitis	0.00112	0.00363	CcSEcCtD
Lisuride—HTR1A—head—atopic dermatitis	0.00111	0.0184	CbGeAlD
Lisuride—Anorexia—Mometasone—atopic dermatitis	0.00111	0.0036	CcSEcCtD
Lisuride—Headache—Dimenhydrinate—atopic dermatitis	0.0011	0.00358	CcSEcCtD
Lisuride—Headache—Diphenhydramine—atopic dermatitis	0.0011	0.00358	CcSEcCtD
Lisuride—Vomiting—Pimecrolimus—atopic dermatitis	0.00108	0.00351	CcSEcCtD
Lisuride—Headache—Pimecrolimus—atopic dermatitis	0.00107	0.00346	CcSEcCtD
Lisuride—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00105	0.00342	CcSEcCtD
Lisuride—Dyspnoea—Mometasone—atopic dermatitis	0.00104	0.00337	CcSEcCtD
Lisuride—Vertigo—Tacrolimus—atopic dermatitis	0.00102	0.00331	CcSEcCtD
Lisuride—Syncope—Tacrolimus—atopic dermatitis	0.00102	0.0033	CcSEcCtD
Lisuride—Decreased appetite—Mometasone—atopic dermatitis	0.00101	0.00328	CcSEcCtD
Lisuride—Fatigue—Mometasone—atopic dermatitis	0.001	0.00326	CcSEcCtD
Lisuride—DRD2—head—atopic dermatitis	0.001	0.0167	CbGeAlD
Lisuride—Palpitations—Tacrolimus—atopic dermatitis	0.001	0.00326	CcSEcCtD
Lisuride—Cough—Tacrolimus—atopic dermatitis	0.00099	0.00321	CcSEcCtD
Lisuride—ADRA2C—head—atopic dermatitis	0.000974	0.0162	CbGeAlD
Lisuride—Asthenia—Loratadine—atopic dermatitis	0.000972	0.00316	CcSEcCtD
Lisuride—Anxiety—Tacrolimus—atopic dermatitis	0.000962	0.00313	CcSEcCtD
Lisuride—Weight increased—Prednisolone—atopic dermatitis	0.000946	0.00307	CcSEcCtD
Lisuride—Dry mouth—Tacrolimus—atopic dermatitis	0.000944	0.00307	CcSEcCtD
Lisuride—Confusional state—Tacrolimus—atopic dermatitis	0.000933	0.00303	CcSEcCtD
Lisuride—Weight increased—Hydrocortisone—atopic dermatitis	0.000924	0.003	CcSEcCtD
Lisuride—Infection—Tacrolimus—atopic dermatitis	0.00092	0.00299	CcSEcCtD
Lisuride—Weight decreased—Hydrocortisone—atopic dermatitis	0.000919	0.00298	CcSEcCtD
Lisuride—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000908	0.00295	CcSEcCtD
Lisuride—Tachycardia—Tacrolimus—atopic dermatitis	0.000903	0.00293	CcSEcCtD
Lisuride—Dizziness—Loratadine—atopic dermatitis	0.000896	0.00291	CcSEcCtD
Lisuride—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000895	0.00291	CcSEcCtD
Lisuride—Anorexia—Tacrolimus—atopic dermatitis	0.000882	0.00287	CcSEcCtD
Lisuride—Weight increased—Triamcinolone—atopic dermatitis	0.00087	0.00283	CcSEcCtD
Lisuride—Weight increased—Methylprednisolone—atopic dermatitis	0.000868	0.00282	CcSEcCtD
Lisuride—Vomiting—Loratadine—atopic dermatitis	0.000862	0.0028	CcSEcCtD
Lisuride—Headache—Loratadine—atopic dermatitis	0.000849	0.00276	CcSEcCtD
Lisuride—Insomnia—Tacrolimus—atopic dermatitis	0.000837	0.00272	CcSEcCtD
Lisuride—Asthenia—Mometasone—atopic dermatitis	0.000834	0.00271	CcSEcCtD
Lisuride—Dyspnoea—Tacrolimus—atopic dermatitis	0.000825	0.00268	CcSEcCtD
Lisuride—Somnolence—Tacrolimus—atopic dermatitis	0.000823	0.00267	CcSEcCtD
Lisuride—Sweating—Methylprednisolone—atopic dermatitis	0.000815	0.00265	CcSEcCtD
Lisuride—Hallucination—Hydrocortisone—atopic dermatitis	0.000809	0.00263	CcSEcCtD
Lisuride—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000805	0.00262	CcSEcCtD
Lisuride—Decreased appetite—Tacrolimus—atopic dermatitis	0.000805	0.00261	CcSEcCtD
Lisuride—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000799	0.0026	CcSEcCtD
Lisuride—Fatigue—Tacrolimus—atopic dermatitis	0.000798	0.00259	CcSEcCtD
Lisuride—Constipation—Tacrolimus—atopic dermatitis	0.000792	0.00257	CcSEcCtD
Lisuride—Weight increased—Dexamethasone—atopic dermatitis	0.000789	0.00256	CcSEcCtD
Lisuride—Weight increased—Betamethasone—atopic dermatitis	0.000789	0.00256	CcSEcCtD
Lisuride—Weight decreased—Dexamethasone—atopic dermatitis	0.000785	0.00255	CcSEcCtD
Lisuride—Weight decreased—Betamethasone—atopic dermatitis	0.000785	0.00255	CcSEcCtD
Lisuride—ADRA2A—head—atopic dermatitis	0.000778	0.0129	CbGeAlD
Lisuride—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000774	0.00252	CcSEcCtD
Lisuride—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000763	0.00248	CcSEcCtD
Lisuride—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000763	0.00248	CcSEcCtD
Lisuride—Hallucination—Methylprednisolone—atopic dermatitis	0.00076	0.00247	CcSEcCtD
Lisuride—Vomiting—Mometasone—atopic dermatitis	0.000739	0.0024	CcSEcCtD
Lisuride—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000734	0.00238	CcSEcCtD
Lisuride—Headache—Mometasone—atopic dermatitis	0.000729	0.00237	CcSEcCtD
Lisuride—Mental disorder—Hydrocortisone—atopic dermatitis	0.000712	0.00231	CcSEcCtD
Lisuride—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000709	0.0023	CcSEcCtD
Lisuride—Malnutrition—Hydrocortisone—atopic dermatitis	0.000707	0.0023	CcSEcCtD
Lisuride—Angiopathy—Methylprednisolone—atopic dermatitis	0.000693	0.00225	CcSEcCtD
Lisuride—Hallucination—Betamethasone—atopic dermatitis	0.000691	0.00224	CcSEcCtD
Lisuride—Hallucination—Dexamethasone—atopic dermatitis	0.000691	0.00224	CcSEcCtD
Lisuride—Immune system disorder—Methylprednisolone—atopic dermatitis	0.00069	0.00224	CcSEcCtD
Lisuride—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000688	0.00224	CcSEcCtD
Lisuride—Weight increased—Prednisone—atopic dermatitis	0.000688	0.00223	CcSEcCtD
Lisuride—Weight decreased—Prednisone—atopic dermatitis	0.000683	0.00222	CcSEcCtD
Lisuride—Mental disorder—Methylprednisolone—atopic dermatitis	0.000669	0.00217	CcSEcCtD
Lisuride—Malnutrition—Methylprednisolone—atopic dermatitis	0.000665	0.00216	CcSEcCtD
Lisuride—Asthenia—Tacrolimus—atopic dermatitis	0.000664	0.00216	CcSEcCtD
Lisuride—HTR2A—head—atopic dermatitis	0.000661	0.011	CbGeAlD
Lisuride—Vertigo—Prednisolone—atopic dermatitis	0.000651	0.00211	CcSEcCtD
Lisuride—Syncope—Prednisolone—atopic dermatitis	0.00065	0.00211	CcSEcCtD
Lisuride—Vertigo—Hydrocortisone—atopic dermatitis	0.000636	0.00206	CcSEcCtD
Lisuride—Syncope—Hydrocortisone—atopic dermatitis	0.000634	0.00206	CcSEcCtD
Lisuride—Angiopathy—Dexamethasone—atopic dermatitis	0.00063	0.00205	CcSEcCtD
Lisuride—Angiopathy—Betamethasone—atopic dermatitis	0.00063	0.00205	CcSEcCtD
Lisuride—Dizziness—Tacrolimus—atopic dermatitis	0.000612	0.00199	CcSEcCtD
Lisuride—CYP2D6—head—atopic dermatitis	0.000602	0.01	CbGeAlD
Lisuride—Hallucination—Prednisone—atopic dermatitis	0.000602	0.00195	CcSEcCtD
Lisuride—Anxiety—Hydrocortisone—atopic dermatitis	0.0006	0.00195	CcSEcCtD
Lisuride—Vertigo—Triamcinolone—atopic dermatitis	0.000599	0.00194	CcSEcCtD
Lisuride—Syncope—Triamcinolone—atopic dermatitis	0.000597	0.00194	CcSEcCtD
Lisuride—Vertigo—Methylprednisolone—atopic dermatitis	0.000597	0.00194	CcSEcCtD
Lisuride—Syncope—Methylprednisolone—atopic dermatitis	0.000596	0.00194	CcSEcCtD
Lisuride—Vomiting—Tacrolimus—atopic dermatitis	0.000589	0.00191	CcSEcCtD
Lisuride—Cough—Triamcinolone—atopic dermatitis	0.000581	0.00189	CcSEcCtD
Lisuride—Headache—Tacrolimus—atopic dermatitis	0.00058	0.00188	CcSEcCtD
Lisuride—Tachycardia—Prednisolone—atopic dermatitis	0.000577	0.00187	CcSEcCtD
Lisuride—Infection—Hydrocortisone—atopic dermatitis	0.000574	0.00186	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000572	0.00186	CcSEcCtD
Lisuride—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000566	0.00184	CcSEcCtD
Lisuride—Anxiety—Methylprednisolone—atopic dermatitis	0.000564	0.00183	CcSEcCtD
Lisuride—Tachycardia—Hydrocortisone—atopic dermatitis	0.000564	0.00183	CcSEcCtD
Lisuride—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000558	0.00181	CcSEcCtD
Lisuride—Dry mouth—Triamcinolone—atopic dermatitis	0.000555	0.0018	CcSEcCtD
Lisuride—Anorexia—Hydrocortisone—atopic dermatitis	0.00055	0.00179	CcSEcCtD
Lisuride—Angiopathy—Prednisone—atopic dermatitis	0.000549	0.00178	CcSEcCtD
Lisuride—Confusional state—Methylprednisolone—atopic dermatitis	0.000547	0.00178	CcSEcCtD
Lisuride—Immune system disorder—Prednisone—atopic dermatitis	0.000546	0.00177	CcSEcCtD
Lisuride—Vertigo—Betamethasone—atopic dermatitis	0.000543	0.00176	CcSEcCtD
Lisuride—Vertigo—Dexamethasone—atopic dermatitis	0.000543	0.00176	CcSEcCtD
Lisuride—Syncope—Betamethasone—atopic dermatitis	0.000542	0.00176	CcSEcCtD
Lisuride—Syncope—Dexamethasone—atopic dermatitis	0.000542	0.00176	CcSEcCtD
Lisuride—Infection—Triamcinolone—atopic dermatitis	0.00054	0.00175	CcSEcCtD
Lisuride—Infection—Methylprednisolone—atopic dermatitis	0.000539	0.00175	CcSEcCtD
Lisuride—Insomnia—Prednisolone—atopic dermatitis	0.000535	0.00174	CcSEcCtD
Lisuride—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000532	0.00173	CcSEcCtD
Lisuride—Tachycardia—Triamcinolone—atopic dermatitis	0.000531	0.00172	CcSEcCtD
Lisuride—Mental disorder—Prednisone—atopic dermatitis	0.00053	0.00172	CcSEcCtD
Lisuride—Tachycardia—Methylprednisolone—atopic dermatitis	0.000529	0.00172	CcSEcCtD
Lisuride—Malnutrition—Prednisone—atopic dermatitis	0.000526	0.00171	CcSEcCtD
Lisuride—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000526	0.00171	CcSEcCtD
Lisuride—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000524	0.0017	CcSEcCtD
Lisuride—Insomnia—Hydrocortisone—atopic dermatitis	0.000522	0.0017	CcSEcCtD
Lisuride—Anxiety—Dexamethasone—atopic dermatitis	0.000513	0.00167	CcSEcCtD
Lisuride—Anxiety—Betamethasone—atopic dermatitis	0.000513	0.00167	CcSEcCtD
Lisuride—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000502	0.00163	CcSEcCtD
Lisuride—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000499	0.00162	CcSEcCtD
Lisuride—Fatigue—Hydrocortisone—atopic dermatitis	0.000498	0.00162	CcSEcCtD
Lisuride—Insomnia—Triamcinolone—atopic dermatitis	0.000492	0.0016	CcSEcCtD
Lisuride—Insomnia—Methylprednisolone—atopic dermatitis	0.000491	0.00159	CcSEcCtD
Lisuride—Infection—Dexamethasone—atopic dermatitis	0.00049	0.00159	CcSEcCtD
Lisuride—Infection—Betamethasone—atopic dermatitis	0.00049	0.00159	CcSEcCtD
Lisuride—Feeling abnormal—Prednisolone—atopic dermatitis	0.000487	0.00158	CcSEcCtD
Lisuride—Dyspnoea—Triamcinolone—atopic dermatitis	0.000485	0.00157	CcSEcCtD
Lisuride—Nervous system disorder—Betamethasone—atopic dermatitis	0.000484	0.00157	CcSEcCtD
Lisuride—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000484	0.00157	CcSEcCtD
Lisuride—Tachycardia—Dexamethasone—atopic dermatitis	0.000481	0.00156	CcSEcCtD
Lisuride—Tachycardia—Betamethasone—atopic dermatitis	0.000481	0.00156	CcSEcCtD
Lisuride—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000477	0.00155	CcSEcCtD
Lisuride—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000477	0.00155	CcSEcCtD
Lisuride—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000476	0.00155	CcSEcCtD
Lisuride—Vertigo—Prednisone—atopic dermatitis	0.000473	0.00154	CcSEcCtD
Lisuride—Syncope—Prednisone—atopic dermatitis	0.000472	0.00153	CcSEcCtD
Lisuride—Anorexia—Betamethasone—atopic dermatitis	0.00047	0.00153	CcSEcCtD
Lisuride—Anorexia—Dexamethasone—atopic dermatitis	0.00047	0.00153	CcSEcCtD
Lisuride—Fatigue—Triamcinolone—atopic dermatitis	0.000469	0.00152	CcSEcCtD
Lisuride—Fatigue—Methylprednisolone—atopic dermatitis	0.000468	0.00152	CcSEcCtD
Lisuride—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000448	0.00146	CcSEcCtD
Lisuride—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000447	0.00145	CcSEcCtD
Lisuride—Anxiety—Prednisone—atopic dermatitis	0.000447	0.00145	CcSEcCtD
Lisuride—Insomnia—Dexamethasone—atopic dermatitis	0.000446	0.00145	CcSEcCtD
Lisuride—Insomnia—Betamethasone—atopic dermatitis	0.000446	0.00145	CcSEcCtD
Lisuride—Decreased appetite—Dexamethasone—atopic dermatitis	0.000429	0.00139	CcSEcCtD
Lisuride—Decreased appetite—Betamethasone—atopic dermatitis	0.000429	0.00139	CcSEcCtD
Lisuride—Infection—Prednisone—atopic dermatitis	0.000427	0.00139	CcSEcCtD
Lisuride—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000426	0.00138	CcSEcCtD
Lisuride—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000426	0.00138	CcSEcCtD
Lisuride—Fatigue—Dexamethasone—atopic dermatitis	0.000425	0.00138	CcSEcCtD
Lisuride—Fatigue—Betamethasone—atopic dermatitis	0.000425	0.00138	CcSEcCtD
Lisuride—Nervous system disorder—Prednisone—atopic dermatitis	0.000421	0.00137	CcSEcCtD
Lisuride—Tachycardia—Prednisone—atopic dermatitis	0.000419	0.00136	CcSEcCtD
Lisuride—Hyperhidrosis—Prednisone—atopic dermatitis	0.000415	0.00135	CcSEcCtD
Lisuride—Asthenia—Hydrocortisone—atopic dermatitis	0.000414	0.00135	CcSEcCtD
Lisuride—Anorexia—Prednisone—atopic dermatitis	0.00041	0.00133	CcSEcCtD
Lisuride—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000407	0.00132	CcSEcCtD
Lisuride—Feeling abnormal—Betamethasone—atopic dermatitis	0.000407	0.00132	CcSEcCtD
Lisuride—Dizziness—Prednisolone—atopic dermatitis	0.000391	0.00127	CcSEcCtD
Lisuride—Asthenia—Triamcinolone—atopic dermatitis	0.00039	0.00127	CcSEcCtD
Lisuride—Asthenia—Methylprednisolone—atopic dermatitis	0.000389	0.00126	CcSEcCtD
Lisuride—Insomnia—Prednisone—atopic dermatitis	0.000389	0.00126	CcSEcCtD
Lisuride—Dizziness—Hydrocortisone—atopic dermatitis	0.000382	0.00124	CcSEcCtD
Lisuride—Decreased appetite—Prednisone—atopic dermatitis	0.000373	0.00121	CcSEcCtD
Lisuride—Fatigue—Prednisone—atopic dermatitis	0.00037	0.0012	CcSEcCtD
Lisuride—Headache—Prednisolone—atopic dermatitis	0.00037	0.0012	CcSEcCtD
Lisuride—Constipation—Prednisone—atopic dermatitis	0.000367	0.00119	CcSEcCtD
Lisuride—Vomiting—Hydrocortisone—atopic dermatitis	0.000367	0.00119	CcSEcCtD
Lisuride—Headache—Hydrocortisone—atopic dermatitis	0.000362	0.00117	CcSEcCtD
Lisuride—Dizziness—Triamcinolone—atopic dermatitis	0.00036	0.00117	CcSEcCtD
Lisuride—Dizziness—Methylprednisolone—atopic dermatitis	0.000359	0.00117	CcSEcCtD
Lisuride—Feeling abnormal—Prednisone—atopic dermatitis	0.000354	0.00115	CcSEcCtD
Lisuride—Asthenia—Dexamethasone—atopic dermatitis	0.000354	0.00115	CcSEcCtD
Lisuride—Asthenia—Betamethasone—atopic dermatitis	0.000354	0.00115	CcSEcCtD
Lisuride—Vomiting—Triamcinolone—atopic dermatitis	0.000346	0.00112	CcSEcCtD
Lisuride—Vomiting—Methylprednisolone—atopic dermatitis	0.000345	0.00112	CcSEcCtD
Lisuride—Headache—Triamcinolone—atopic dermatitis	0.000341	0.00111	CcSEcCtD
Lisuride—Headache—Methylprednisolone—atopic dermatitis	0.00034	0.0011	CcSEcCtD
Lisuride—Dizziness—Betamethasone—atopic dermatitis	0.000326	0.00106	CcSEcCtD
Lisuride—Dizziness—Dexamethasone—atopic dermatitis	0.000326	0.00106	CcSEcCtD
Lisuride—Vomiting—Dexamethasone—atopic dermatitis	0.000314	0.00102	CcSEcCtD
Lisuride—Vomiting—Betamethasone—atopic dermatitis	0.000314	0.00102	CcSEcCtD
Lisuride—Headache—Dexamethasone—atopic dermatitis	0.000309	0.001	CcSEcCtD
Lisuride—Headache—Betamethasone—atopic dermatitis	0.000309	0.001	CcSEcCtD
Lisuride—Asthenia—Prednisone—atopic dermatitis	0.000308	0.001	CcSEcCtD
Lisuride—Dizziness—Prednisone—atopic dermatitis	0.000284	0.000923	CcSEcCtD
Lisuride—Vomiting—Prednisone—atopic dermatitis	0.000273	0.000887	CcSEcCtD
Lisuride—Headache—Prednisone—atopic dermatitis	0.000269	0.000874	CcSEcCtD
Lisuride—DRD2—Signaling by GPCR—CCR5—atopic dermatitis	4.68e-05	0.000208	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—NFKBIA—atopic dermatitis	4.67e-05	0.000208	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCL10—atopic dermatitis	4.66e-05	0.000207	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCL10—atopic dermatitis	4.66e-05	0.000207	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	4.66e-05	0.000207	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CCL5—atopic dermatitis	4.65e-05	0.000207	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CCR5—atopic dermatitis	4.61e-05	0.000205	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL5—atopic dermatitis	4.61e-05	0.000205	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CCR5—atopic dermatitis	4.6e-05	0.000205	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CCL5—atopic dermatitis	4.59e-05	0.000204	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—CXCL8—atopic dermatitis	4.58e-05	0.000204	CbGpPWpGaD
Lisuride—HTR1D—GPCR downstream signaling—IL2—atopic dermatitis	4.55e-05	0.000202	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL5—atopic dermatitis	4.53e-05	0.000201	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCR3—atopic dermatitis	4.52e-05	0.000201	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CCL5—atopic dermatitis	4.51e-05	0.000201	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—TAC1—atopic dermatitis	4.5e-05	0.0002	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NPS—atopic dermatitis	4.5e-05	0.0002	CbGpPWpGaD
Lisuride—HTR1B—GPCR downstream signaling—IL2—atopic dermatitis	4.45e-05	0.000198	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—TAC1—atopic dermatitis	4.42e-05	0.000197	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NPS—atopic dermatitis	4.42e-05	0.000197	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCR3—atopic dermatitis	4.41e-05	0.000196	CbGpPWpGaD
Lisuride—DRD4—GPCR downstream signaling—IL2—atopic dermatitis	4.38e-05	0.000195	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	4.38e-05	0.000194	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NGF—atopic dermatitis	4.34e-05	0.000193	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCR3—atopic dermatitis	4.34e-05	0.000193	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—CXCL8—atopic dermatitis	4.32e-05	0.000192	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	4.31e-05	0.000191	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NGF—atopic dermatitis	4.25e-05	0.000189	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	4.24e-05	0.000189	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—CXCL8—atopic dermatitis	4.23e-05	0.000188	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CCR5—atopic dermatitis	4.22e-05	0.000187	CbGpPWpGaD
Lisuride—ADRA2A—Hemostasis—IL2—atopic dermatitis	4.22e-05	0.000187	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL10—atopic dermatitis	4.21e-05	0.000187	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CCR5—atopic dermatitis	4.19e-05	0.000186	CbGpPWpGaD
Lisuride—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	4.18e-05	0.000186	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NGF—atopic dermatitis	4.18e-05	0.000186	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL5—atopic dermatitis	4.18e-05	0.000186	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—CXCL8—atopic dermatitis	4.16e-05	0.000185	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CCR5—atopic dermatitis	4.13e-05	0.000184	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL2—atopic dermatitis	4.13e-05	0.000183	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	4.13e-05	0.000183	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL5—atopic dermatitis	4.11e-05	0.000183	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—CXCL8—atopic dermatitis	4.07e-05	0.000181	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—CXCL8—atopic dermatitis	4.07e-05	0.000181	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CCR5—atopic dermatitis	4.07e-05	0.000181	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCL5—atopic dermatitis	4.06e-05	0.000181	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	4.06e-05	0.00018	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL2—atopic dermatitis	4.04e-05	0.00018	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	4.04e-05	0.000179	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—TAC1—atopic dermatitis	4.03e-05	0.000179	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NPS—atopic dermatitis	4.03e-05	0.000179	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCL5—atopic dermatitis	4.01e-05	0.000178	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCL5—atopic dermatitis	4.01e-05	0.000178	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NGF—atopic dermatitis	3.99e-05	0.000177	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL2—atopic dermatitis	3.98e-05	0.000177	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	3.97e-05	0.000176	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCR3—atopic dermatitis	3.95e-05	0.000175	CbGpPWpGaD
Lisuride—DRD1—GPCR downstream signaling—IL2—atopic dermatitis	3.94e-05	0.000175	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL10—atopic dermatitis	3.93e-05	0.000174	CbGpPWpGaD
Lisuride—DRD3—GPCR downstream signaling—IL2—atopic dermatitis	3.89e-05	0.000173	CbGpPWpGaD
Lisuride—ADRA1D—GPCR downstream signaling—IL2—atopic dermatitis	3.89e-05	0.000173	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	3.88e-05	0.000172	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL10—atopic dermatitis	3.87e-05	0.000172	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	3.8e-05	0.000169	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NGF—atopic dermatitis	3.76e-05	0.000167	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—CXCL8—atopic dermatitis	3.75e-05	0.000166	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL5—atopic dermatitis	3.74e-05	0.000166	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—GLB1—atopic dermatitis	3.72e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NGF—atopic dermatitis	3.71e-05	0.000165	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NGF—atopic dermatitis	3.71e-05	0.000165	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	3.71e-05	0.000165	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—CXCL8—atopic dermatitis	3.7e-05	0.000164	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—CXCL8—atopic dermatitis	3.7e-05	0.000164	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—CXCL8—atopic dermatitis	3.68e-05	0.000163	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CCR5—atopic dermatitis	3.66e-05	0.000163	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	3.65e-05	0.000162	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCL5—atopic dermatitis	3.62e-05	0.000161	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CCR5—atopic dermatitis	3.61e-05	0.00016	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CCR5—atopic dermatitis	3.61e-05	0.00016	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL2—atopic dermatitis	3.58e-05	0.000159	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—NFKBIA—atopic dermatitis	3.58e-05	0.000159	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—ADSL—atopic dermatitis	3.57e-05	0.000159	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL10—atopic dermatitis	3.56e-05	0.000158	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.55e-05	0.000158	CbGpPWpGaD
Lisuride—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	3.55e-05	0.000157	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL2—atopic dermatitis	3.53e-05	0.000157	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL2—atopic dermatitis	3.53e-05	0.000157	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	3.53e-05	0.000157	CbGpPWpGaD
Lisuride—ADRA2B—GPCR downstream signaling—IL2—atopic dermatitis	3.51e-05	0.000156	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL10—atopic dermatitis	3.51e-05	0.000156	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—NFKBIA—atopic dermatitis	3.5e-05	0.000156	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	3.49e-05	0.000155	CbGpPWpGaD
Lisuride—ADRA2C—Metabolism—PPARA—atopic dermatitis	3.49e-05	0.000155	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	3.48e-05	0.000154	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—NFKBIA—atopic dermatitis	3.45e-05	0.000153	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—CXCL8—atopic dermatitis	3.43e-05	0.000153	CbGpPWpGaD
Lisuride—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	3.39e-05	0.000151	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NGF—atopic dermatitis	3.38e-05	0.00015	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCL5—atopic dermatitis	3.38e-05	0.00015	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—CXCL8—atopic dermatitis	3.38e-05	0.00015	CbGpPWpGaD
Lisuride—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	3.37e-05	0.00015	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	3.37e-05	0.00015	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NGF—atopic dermatitis	3.35e-05	0.000149	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—CXCL8—atopic dermatitis	3.34e-05	0.000148	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—CXCL8—atopic dermatitis	3.33e-05	0.000148	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCL5—atopic dermatitis	3.33e-05	0.000148	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	3.29e-05	0.000146	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	3.29e-05	0.000146	CbGpPWpGaD
Lisuride—ADRA2C—GPCR downstream signaling—IL2—atopic dermatitis	3.28e-05	0.000146	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CCR5—atopic dermatitis	3.26e-05	0.000145	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NGF—atopic dermatitis	3.24e-05	0.000144	CbGpPWpGaD
Lisuride—ADRA1B—GPCR downstream signaling—IL2—atopic dermatitis	3.23e-05	0.000143	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	3.22e-05	0.000143	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NGF—atopic dermatitis	3.22e-05	0.000143	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	3.22e-05	0.000143	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	3.21e-05	0.000142	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL10—atopic dermatitis	3.19e-05	0.000142	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL2—atopic dermatitis	3.19e-05	0.000142	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL2—atopic dermatitis	3.18e-05	0.000141	CbGpPWpGaD
Lisuride—DRD5—Signaling by GPCR—IL6—atopic dermatitis	3.17e-05	0.000141	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	3.15e-05	0.00014	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	3.13e-05	0.000139	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NGF—atopic dermatitis	3.13e-05	0.000139	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—CXCL8—atopic dermatitis	3.12e-05	0.000138	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—CXCL8—atopic dermatitis	3.12e-05	0.000138	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—NFKBIA—atopic dermatitis	3.1e-05	0.000138	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NGF—atopic dermatitis	3.08e-05	0.000137	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	3.08e-05	0.000137	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—CXCL8—atopic dermatitis	3.07e-05	0.000136	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCL5—atopic dermatitis	3.07e-05	0.000136	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—CXCL8—atopic dermatitis	3.07e-05	0.000136	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	3.06e-05	0.000136	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—NFKBIA—atopic dermatitis	3.06e-05	0.000136	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—NFKBIA—atopic dermatitis	3.06e-05	0.000136	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CCR5—atopic dermatitis	3.05e-05	0.000135	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCL5—atopic dermatitis	3.02e-05	0.000134	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CCR5—atopic dermatitis	3e-05	0.000133	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL2—atopic dermatitis	2.98e-05	0.000132	CbGpPWpGaD
Lisuride—DRD2—GPCR downstream signaling—IL2—atopic dermatitis	2.98e-05	0.000132	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL2—atopic dermatitis	2.93e-05	0.00013	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—MAPK8—atopic dermatitis	2.93e-05	0.00013	CbGpPWpGaD
Lisuride—HTR2A—GPCR downstream signaling—IL2—atopic dermatitis	2.93e-05	0.00013	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NGF—atopic dermatitis	2.84e-05	0.000126	CbGpPWpGaD
Lisuride—ADRA2A—Metabolism—PPARA—atopic dermatitis	2.84e-05	0.000126	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—CXCL8—atopic dermatitis	2.83e-05	0.000126	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NGF—atopic dermatitis	2.8e-05	0.000124	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	2.79e-05	0.000124	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—CXCL8—atopic dermatitis	2.79e-05	0.000124	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.78e-05	0.000124	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—NFKBIA—atopic dermatitis	2.76e-05	0.000123	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CCR5—atopic dermatitis	2.76e-05	0.000123	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCL5—atopic dermatitis	2.75e-05	0.000122	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CCR5—atopic dermatitis	2.72e-05	0.000121	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL2—atopic dermatitis	2.7e-05	0.00012	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	2.67e-05	0.000119	CbGpPWpGaD
Lisuride—ADRA2A—GPCR downstream signaling—IL2—atopic dermatitis	2.67e-05	0.000118	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL2—atopic dermatitis	2.66e-05	0.000118	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	2.66e-05	0.000118	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—NFKBIA—atopic dermatitis	2.58e-05	0.000115	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—CXCL8—atopic dermatitis	2.55e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NGF—atopic dermatitis	2.54e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—NFKBIA—atopic dermatitis	2.54e-05	0.000113	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—CXCL8—atopic dermatitis	2.53e-05	0.000112	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—CXCL8—atopic dermatitis	2.5e-05	0.000111	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CCR5—atopic dermatitis	2.47e-05	0.00011	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—CXCL8—atopic dermatitis	2.46e-05	0.000109	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL2—atopic dermatitis	2.44e-05	0.000108	CbGpPWpGaD
Lisuride—HTR1D—Signaling by GPCR—IL6—atopic dermatitis	2.43e-05	0.000108	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL2—atopic dermatitis	2.42e-05	0.000108	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL2—atopic dermatitis	2.39e-05	0.000106	CbGpPWpGaD
Lisuride—HTR1B—Signaling by GPCR—IL6—atopic dermatitis	2.38e-05	0.000106	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL2—atopic dermatitis	2.35e-05	0.000104	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	2.35e-05	0.000104	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—NFKBIA—atopic dermatitis	2.34e-05	0.000104	CbGpPWpGaD
Lisuride—DRD4—Signaling by GPCR—IL6—atopic dermatitis	2.34e-05	0.000104	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.31e-05	0.000102	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—MAPK8—atopic dermatitis	2.24e-05	9.97e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL2—atopic dermatitis	2.24e-05	9.96e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	2.23e-05	9.91e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—CXCL8—atopic dermatitis	2.21e-05	9.83e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—MAPK8—atopic dermatitis	2.2e-05	9.76e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—CXCL8—atopic dermatitis	2.18e-05	9.7e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—CXCL8—atopic dermatitis	2.18e-05	9.7e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—MAPK8—atopic dermatitis	2.16e-05	9.61e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL2—atopic dermatitis	2.12e-05	9.4e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling by GPCR—IL6—atopic dermatitis	2.1e-05	9.35e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—NFKBIA—atopic dermatitis	2.1e-05	9.32e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL2—atopic dermatitis	2.09e-05	9.27e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL2—atopic dermatitis	2.09e-05	9.27e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling by GPCR—IL6—atopic dermatitis	2.08e-05	9.22e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling by GPCR—IL6—atopic dermatitis	2.08e-05	9.22e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	2.06e-05	9.17e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	1.99e-05	8.84e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—CXCL8—atopic dermatitis	1.97e-05	8.76e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—MAPK8—atopic dermatitis	1.95e-05	8.65e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—MAPK8—atopic dermatitis	1.92e-05	8.53e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—MAPK8—atopic dermatitis	1.92e-05	8.53e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	1.9e-05	8.45e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL2—atopic dermatitis	1.9e-05	8.45e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	1.89e-05	8.41e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	1.89e-05	8.41e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL2—atopic dermatitis	1.88e-05	8.37e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling by GPCR—IL6—atopic dermatitis	1.87e-05	8.33e-05	CbGpPWpGaD
Lisuride—DRD5—Signaling Pathways—IL6—atopic dermatitis	1.87e-05	8.31e-05	CbGpPWpGaD
Lisuride—CYP2D6—Metabolism—PPARA—atopic dermatitis	1.85e-05	8.21e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—CXCL8—atopic dermatitis	1.84e-05	8.18e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL2—atopic dermatitis	1.82e-05	8.08e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—CXCL8—atopic dermatitis	1.81e-05	8.05e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	1.81e-05	8.04e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL2—atopic dermatitis	1.81e-05	8.04e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	1.8e-05	8e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL2—atopic dermatitis	1.76e-05	7.82e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling by GPCR—IL6—atopic dermatitis	1.75e-05	7.78e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	1.75e-05	7.78e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—MAPK8—atopic dermatitis	1.73e-05	7.7e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL2—atopic dermatitis	1.73e-05	7.69e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling by GPCR—IL6—atopic dermatitis	1.72e-05	7.66e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	1.67e-05	7.44e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—CXCL8—atopic dermatitis	1.67e-05	7.42e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	1.67e-05	7.4e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—CXCL8—atopic dermatitis	1.64e-05	7.3e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—MAPK8—atopic dermatitis	1.62e-05	7.2e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL2—atopic dermatitis	1.6e-05	7.09e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—MAPK8—atopic dermatitis	1.59e-05	7.08e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling by GPCR—IL6—atopic dermatitis	1.59e-05	7.06e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL2—atopic dermatitis	1.57e-05	6.98e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling by GPCR—IL6—atopic dermatitis	1.56e-05	6.95e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—CXCL8—atopic dermatitis	1.5e-05	6.65e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-05	6.53e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—MAPK8—atopic dermatitis	1.45e-05	6.43e-05	CbGpPWpGaD
Lisuride—HTR1D—Signaling Pathways—IL6—atopic dermatitis	1.43e-05	6.37e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL2—atopic dermatitis	1.43e-05	6.35e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling by GPCR—IL6—atopic dermatitis	1.42e-05	6.32e-05	CbGpPWpGaD
Lisuride—HTR1B—Signaling Pathways—IL6—atopic dermatitis	1.4e-05	6.23e-05	CbGpPWpGaD
Lisuride—DRD4—Signaling Pathways—IL6—atopic dermatitis	1.38e-05	6.14e-05	CbGpPWpGaD
Lisuride—HTR2B—Signaling Pathways—IL6—atopic dermatitis	1.32e-05	5.86e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—MAPK8—atopic dermatitis	1.32e-05	5.85e-05	CbGpPWpGaD
Lisuride—DRD1—Signaling Pathways—IL6—atopic dermatitis	1.24e-05	5.52e-05	CbGpPWpGaD
Lisuride—ADRA1D—Signaling Pathways—IL6—atopic dermatitis	1.23e-05	5.45e-05	CbGpPWpGaD
Lisuride—DRD3—Signaling Pathways—IL6—atopic dermatitis	1.23e-05	5.45e-05	CbGpPWpGaD
Lisuride—CYP3A4—Metabolism—PPARA—atopic dermatitis	1.21e-05	5.37e-05	CbGpPWpGaD
Lisuride—ADRB1—Signaling Pathways—IL6—atopic dermatitis	1.12e-05	4.97e-05	CbGpPWpGaD
Lisuride—ADRA2B—Signaling Pathways—IL6—atopic dermatitis	1.11e-05	4.92e-05	CbGpPWpGaD
Lisuride—HTR1A—Signaling Pathways—IL6—atopic dermatitis	1.07e-05	4.75e-05	CbGpPWpGaD
Lisuride—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.06e-05	4.72e-05	CbGpPWpGaD
Lisuride—ADRA2C—Signaling Pathways—IL6—atopic dermatitis	1.03e-05	4.6e-05	CbGpPWpGaD
Lisuride—ADRA1B—Signaling Pathways—IL6—atopic dermatitis	1.02e-05	4.52e-05	CbGpPWpGaD
Lisuride—DRD2—Signaling Pathways—IL6—atopic dermatitis	9.39e-06	4.17e-05	CbGpPWpGaD
Lisuride—HTR2A—Signaling Pathways—IL6—atopic dermatitis	9.24e-06	4.1e-05	CbGpPWpGaD
Lisuride—ADRA2A—Signaling Pathways—IL6—atopic dermatitis	8.4e-06	3.73e-05	CbGpPWpGaD
